OverviewChartNewsTraderScreen

DZ Bank Bonus Zert SNW 28.03.2025/  DE000DJ2UEX3  /

Frankfurt Zert./DZB
10/11/2024  9:34:15 PM Chg.+0.090 Bid9:58:03 PM Ask9:58:03 PM Underlying Strike price Expiration date Option type
116.970EUR +0.08% 116.990
Bid Size: 125		 117.040
Ask Size: 125		 SANOFI SA INHABER ... - EUR 3/28/2025 Call
GlobeNewswire 9/2 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 8/26 Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire 8/14 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 8/13 Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/12 MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter ...
GlobeNewswire 8/12 MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
GlobeNewswire 8/8 Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free sur...
GlobeNewswire 8/6 Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D ...
GlobeNewswire 8/5 Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
GlobeNewswire 8/2 Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
GlobeNewswire 8/1 Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 8/1 Regeneron Reports Second Quarter 2024 Financial and Operating Results
GlobeNewswire 7/31 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2...
GlobeNewswire 7/25 Press Release: Online availability of Sanofi’s half-year financial report for 2024
TeleTrader 7/25 Europe lower premarket as earnings pour in
TeleTrader 7/25 Sanofi net sales up 7.8% to €10.7B in Q2
GlobeNewswire 7/25 Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
GlobeNewswire 7/24 US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold...
GlobeNewswire 7/18 Takeda’s Eohilia Sees Strong Early Adoption and Growth Potential in Eosinophilic Esophagitis, Accord...
GlobeNewswire 7/17 Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transfor...
GlobeNewswire 7/12 FluGen’s Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults Shows ...
GlobeNewswire 7/11 Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Upd...
GlobeNewswire 7/8 Kymera Announces Expansion of KT-474 (SAR444656) HS and AD Phase 2 Studies Following Interim Review ...
GlobeNewswire 7/3 Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients...
GlobeNewswire 7/3 Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD